P01-09: Development of an Adverse Outcome Pathway study of renal failure induced by uranium using in vitro models: hRPTEC TERT1 and kidney organoids
Frerejacques, M., Steichen, C., Jacquard Fevai, M., Brishoual, S., Suhard, D., Powell, V., Bouvier-Capely, C., Hauet, T., Guéguen, Y.
Published in Toxicology letters (01.09.2023)
Published in Toxicology letters (01.09.2023)
Get full text
Journal Article
P01-09: Development of an Adverse Outcome Pathway study of renal failure induced by uranium usingin vitromodels: hRPTEC TERT1 and kidney organoids
Frerejacques, M., Steichen, C., Jacquard Fevai, M., Brishoual, S., Suhard, D., Powell, V., Bouvier-Capely, C., Hauet, T., Guéguen, Y.
Published in Toxicology letters (01.09.2023)
Published in Toxicology letters (01.09.2023)
Get full text
Journal Article
Human cardiomyocytes derived from induced pluripotent stem cells
Steichen, C., Jacquard-Fevai, M., Brishoual, S., Hauet, T.
Published in Computer methods in biomechanics and biomedical engineering (01.05.2019)
Published in Computer methods in biomechanics and biomedical engineering (01.05.2019)
Get full text
Journal Article
Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohort: Diabetologia
Gellen, B., Thorin-Trescases, N., Thorin, E., Gand, E., Sosner, P., Brishoual, S., Rigalleau, Vincent, Montaigne, D., Javaugue, V., Pucheu, Y., Gatault, P., Piguel, X., Hadjadj, S., Saulnier, P. J.
Published in Diabetologia (2020)
Published in Diabetologia (2020)
Get full text
Journal Article
Serum Tenascin-C is independently associated with increased major adverse cardiovascular events and death in patients with type II diabetes
Gellen, B., Thorin-Trescases, N., Thorin, E., Gand, E., Sosner, P., Brishoual, S., Fraty, M., Hadjadj, S., Saulnier, P.J.
Published in Archives of Cardiovascular Diseases Supplements (01.01.2020)
Published in Archives of Cardiovascular Diseases Supplements (01.01.2020)
Get full text
Journal Article